The main goal of this project is to elucidate structural and mechanistic details about the assembly and regulation of the membrane attack complex of complement (MAC). The mechanism of killing by complement involves the formation of a cytolytic pore-forming complex on the membrane of target cells. The insertion of a complex containing components C5b, C6, C7 and C8 is followed by the attachment of C9 which polymerizes to form a pore in the membrane. The process is species specific. Human blood and vascular cells contain a lipid-anchored protein, CD59, that protects them from attack by homologous complement. The previous grant period was devoted largely to characterizing the physical and functional properties of this protein. It was shown that CD59 binds to neo-epitopes on C8-alpha and C9, thereby restricting the assembly of the C9 polymer. The present proposal aims to identify specific residues of C8-alpha and C9 that are recognized by CD59 and vice versa (aims 1 and 2) and to examine the kinetic mechanism of these interactions (aim 4). The sites of interaction of C9 with itself and with C8-alpha will also be localized in an effort to better understand the assembly of the MAC (aim 3).
These aims will be approached through a combination of physical and molecular biological approaches. A fifth aim of lower priority involves a collaborative effort to clarify the role of CD59 as an accessory ligand to CD2 in augmenting T-cell response to antigen presenting cells. These studies are designed to provide new insights into the associative interactions and conformational changes that underlie the expression of the pore-forming function of the C5b-9 complex and the regulation of this process by cell surface CD59.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Method to Extend Research in Time (MERIT) Award (R37)
Project #
5R37HL036061-15
Application #
6056189
Study Section
Hematology Subcommittee 2 (HEM)
Project Start
1985-09-01
Project End
2000-08-31
Budget Start
1999-09-01
Budget End
2000-08-31
Support Year
15
Fiscal Year
1999
Total Cost
Indirect Cost
Name
Scripps Research Institute
Department
Type
DUNS #
City
La Jolla
State
CA
Country
United States
Zip Code
92037
Giddings, Kara S; Zhao, Ji; Sims, Peter J et al. (2004) Human CD59 is a receptor for the cholesterol-dependent cytolysin intermedilysin. Nat Struct Mol Biol 11:1173-8
Sims, P J; Wiedmer, T (2001) Unraveling the mysteries of phospholipid scrambling. Thromb Haemost 86:266-75
Zhao, X J; Zhao, J; Zhou, Q et al. (1998) Identity of the residues responsible for the species-restricted complement inhibitory function of human CD59. J Biol Chem 273:10665-71
Christiansen, V J; Sims, P J; Hamilton, K K (1997) Complement C5b-9 increases plasminogen binding and activation on human endothelial cells. Arterioscler Thromb Vasc Biol 17:164-71
Husler, T; Lockert, D H; Sims, P J (1996) Role of a disulfide-bonded peptide loop within human complement C9 in the species-selectivity of complement inhibitor CD59. Biochemistry 35:3263-9
Petranka, J; Zhao, J; Norris, J et al. (1996) Structure-function relationships of the complement regulatory protein, CD59. Blood Cells Mol Dis 22:281-96
Zhou, Q; Zhao, J; Husler, T et al. (1996) Expression of recombinant CD59 with an N-terminal peptide epitope facilitates analysis of residues contributing to its complement-inhibitory function. Mol Immunol 33:1127-34
Rother, R P; Zhao, J; Zhou, Q et al. (1996) Elimination of potential sites of glycosylation fails to abrogate complement regulatory function of cell surface CD59. J Biol Chem 271:23842-5
Lockert, D H; Kaufman, K M; Chang, C P et al. (1995) Identity of the segment of human complement C8 recognized by complement regulatory protein CD59. J Biol Chem 270:19723-8
Husler, T; Lockert, D H; Kaufman, K M et al. (1995) Chimeras of human complement C9 reveal the site recognized by complement regulatory protein CD59. J Biol Chem 270:3483-6

Showing the most recent 10 out of 38 publications